{"id":5740,"date":"2019-06-17T15:42:27","date_gmt":"2019-06-17T13:42:27","guid":{"rendered":"http:\/\/wordpress.p545550.webspaceconfig.de\/uncategorized\/11-biotech-presse-lounge-am-16-mai-2019\/"},"modified":"2020-07-15T11:33:21","modified_gmt":"2020-07-15T09:33:21","slug":"11-biotech-presse-lounge-am-16-mai-2019","status":"publish","type":"post","link":"https:\/\/www.izb-online.de\/en\/11-biotech-presse-lounge-am-16-mai-2019\/","title":{"rendered":"11th Biotech Press Lounge on the 16th of Mai 2019"},"content":{"rendered":"

[vc_row el_class=”gco-magazine-container”][vc_column el_class=”bildspalte”][vc_row_inner][vc_column_inner offset=”vc_col-lg-12 vc_col-md-12″][vc_column_text el_class=”gco-magazine–title”]<\/p>\n

11th Biotech Press Lounge: Top researchers met industry experts in
\nthe Faculty Club at the IZB<\/span><\/h1>\n

[\/vc_column_text][vc_column_text el_class=”gco-magazine–post-date”]June 2019[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=”two-columns”][vc_column_inner][vc_single_image image=”5726″ img_size=”full”][vc_column_text el_class=”gco-magazine-copyright”]\u00a9 IZB[\/vc_column_text][vc_column_text el_class=”gco-magazine-picture-discription”]Dr. Michael Almstetter
\nCEO, Origenis GmbH[\/vc_column_text][vc_single_image image=”5732″ img_size=”full”][vc_column_text el_class=”gco-magazine-copyright”]\u00a9 IZB[\/vc_column_text][vc_column_text el_class=”gco-magazine-picture-discription”]\u00adSebastian Grabert
\nDirector \u2013 Germany Representative, EURONEXT N.V.[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=”gco-magazine-container–copy”][vc_column_inner][vc_column_text]Gateway to Biotech: Top researchers met industry experts in the Faculty Club at the IZB
\n<\/strong><\/p>\n

Are heart transplants with genetically modified pig hearts within reach? How can the advances in oncology also open up new therapies for Alzheimer’s and Parkinson’s disease? What opportunities exist for partnering with a biopharmaceutical company? And how can the stock markets strengthen the European life sciences sector?
\nAt the eleventh Biotech Press Lounge on May 16, 2019, four speakers addressed 100 participants: Prof. Dr. Dr. h.c. Bruno Reichart of the clinic of the University Munich, Dr. med. \u00adMichael Almstetter, Managing Director of Origenis GmbH, Dr. Ing. Joachim Vogt, Director of Search and Evaluation (S&E), Western Europe at AbbVie Germany GmbH & Co. KG, and Sebastian Grabert, Germany representative of Euronext N.V. Dr. Martin Laqua, senior editor at Transcript, led the program.[\/vc_column_text][vc_column_text css=”.vc_custom_1583761043671{background-color: #1e73be !important;}” el_class=”redaktionell”][\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=”gco-magazine–quote gco-magazine–quote-vertical-center”][vc_column_inner][vc_column_text]<\/p>\n

\"Prof.-Dr.-Dr.-h.c.-Bruno-Reichart\"
\n\u00a9 IZB<\/span><\/div>\n
\n
\u201cI was a guest at the Biotech Press Lounge for the first time and was amazed at how many interesting people had gathered there. The concept was very well thought out, very good and profound questions\u2014I hope the answers were too.\u201d<\/h6>\n

Prof. Dr. Dr. h.c. Bruno Reichart
\nClinic of the University Munich<\/p>\n<\/div>\n

[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=”gco-magazine-container–copy”][vc_column_inner][vc_column_text]He first announced Prof. Reichart, who spoke about the long-term success of heart transplants with genetically modified pig hearts. The organs of genetically modified (xenogeneic) pigs are a promising alternative for terminally ill patients. He was followed by Dr. Michael Almstetter, who explained how advances in oncology can be used to develop new treatments for Alzheimer’s and Parkinson’s disease. Dr. Joachim Vogt presented cooperation opportunities with AbbVie and emphasized the importance of cooperation for the success of medical research. Finally, the 100 attendees learned from Sebastian Grabert, Germany representative of Euronext N.V., how the stock markets can strengthen the life sciences \u00adsector. The task of the stock exchanges is to provide companies access to industry-specific as well as generalist-oriented investors worldwide. Following the talks the speakers engaged in intensive exchange of ideas and networking with the participants of the event.
\n[\/vc_column_text][vc_column_text css=”.vc_custom_1583761043671{background-color: #1e73be !important;}” el_class=”redaktionell”][\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=”gco-magazine–quote gco-magazine–quote-vertical-center”][vc_column_inner][vc_column_text]<\/p>\n

\"Dr.-Joachim-Vogt\"
\n\u00a9 IZB<\/span><\/div>\n
\n
\u201cAt AbbVie we are passionate about innovation, e.g. in oncology, immunology or neuroscience. The Biotech Press Lounge is a great opportunity to connect with the vibrant Munich biotech cluster.\u201d<\/h6>\n

Dr. Joachim Vogt
\nDirector Search and Evaluation (S&E), Western Europe, AbbVie Deutschland GmbH & Co. KG<\/p>\n<\/div>\n

[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=”gco-magazine–quote-gal” css=”.vc_custom_1591802679677{margin-top: 35px !important;margin-bottom: 22px !important;}”][vc_column_inner][vc_column_text css=”.vc_custom_1591802974115{margin-top: 32px !important;}”]

[vc_section el_class=”gco-layout”][vc_row el_class=”bildergalerie-outer”][vc_column][vc_row_inner][vc_column_inner el_class=”bildergalerie-content” width=”1\/4″][vc_single_image image=”9466″ img_size=”full” onclick=”link_image”][\/vc_column_inner][vc_column_inner el_class=”bildergalerie-content” width=”1\/4″][vc_single_image image=”9468″ img_size=”full” onclick=”link_image”][\/vc_column_inner][vc_column_inner el_class=”bildergalerie-content” width=”1\/4″][vc_single_image image=”9470″ img_size=”full” onclick=”link_image”][\/vc_column_inner][vc_column_inner el_class=”bildergalerie-content” width=”1\/4″][vc_single_image image=”9472″ img_size=”full” onclick=”link_image”][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner el_class=”bildergalerie-content” width=”1\/4″][vc_single_image image=”9474″ img_size=”full” onclick=”link_image”][\/vc_column_inner][vc_column_inner el_class=”bildergalerie-content” width=”1\/4″][vc_single_image image=”9476″ img_size=”full” onclick=”link_image”][\/vc_column_inner][vc_column_inner el_class=”bildergalerie-content” width=”1\/4″][vc_single_image image=”9478″ img_size=”full” onclick=”link_image”][\/vc_column_inner][vc_column_inner el_class=”bildergalerie-content” width=”1\/4″][vc_single_image image=”9480″ img_size=”full” onclick=”link_image”][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text el_class=”small-body-everywhere” css=”.vc_custom_1598363848565{margin-top: 13px !important;}”]11th Biotech Press Lounge im Faculty Club G2B[\/vc_column_text][\/vc_column][\/vc_row][\/vc_section]<\/p>\n<\/div><\/div>[\/vc_column_text][vc_column_text el_class=”small-body-everywhere” css=”.vc_custom_1591802548721{padding-bottom: 21px !important;}”]<\/p>\n

Alle Infos rund um die Biotech Press-Lounge ..<\/a><\/p>\n

[\/vc_column_text][vc_column_text css=”.vc_custom_1583761043671{background-color: #1e73be !important;}” el_class=”redaktionell”][\/vc_column_text][\/vc_column_inner][\/vc_row_inner]\n\n

\n \n